Voice of Wits
11 November 2020
As the Alliance’s lead on research, Wilfred oversees the conceptualization, design, sector ownership, implementation, and reporting of all research-related actives, partnerships, and engagements. He thinks about study design, strategic research partnerships, the design, and development of data collection instruments, how results are reported on, published, and presented, and ultimately how results are translated to inform decision making and resource allocation. Wilfred was hosted by #TheChatroomOnVOW , to speak about pre-exposure prophylaxis (or PrEP). This is when people at risk for HIV take daily medicine to prevent HIV…
PrEP can stop HIV from taking hold and spreading throughout your body. When taken daily, PrEP is highly effective for preventing HIV from sex or injection drug use.
In this interview listen to Wilfred explain why PrEP is much less effective when it is not taken consistently. Studies have shown that PrEP reduces the risk of getting HIV from sex by about 99% when taken daily. Among people who inject drugs, PrEP reduces the risk of getting HIV by at least 74% when taken daily.
COVID-19 Clinical Trials Comes Under Fire In Cape Town
12 June 2020
Founder and Lead of the African Alliance, queer advocate and member of the Ministerial Advisory Committee on the COVID-19 vaccine (MAC) mandated to develop a COVID-19 vaccine allocation framework for South Africa and provide recommendations to the MAC – Tian (them/they) has, for nearly two decades, working on a vast range of development areas with a track record of navigating and influencing policy and community spaces from “grassroots” to “grasstops”. Tian spoke to Radio 786 to share their thoughts about one of South Africa’s COVID-19 treatment trials called TASK. This trial is looking at BCG revaccination for healthcare workers in the context of COVID-19.